H.R. 8333 118th Congress
BIOSECURE Act
Latest action, Sep 10, 2024: Received in the Senate and Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
How the House voted: On Motion to Suspend the Rules and Pass, as Amended
Sep 9, 2024 · Passed · 306–81 (it needed 2/3)
- Yea (306)
- Nay (81)
- Didn't vote (44)
- Letters: party (D, R, I)
By party
- Democrat
- Republican
- Independent
14 cosponsors
Sponsored by Brad R. Wenstrup (Republican). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
7 D · 7 R
- Democrat
- Republican
- Independent
Referred to: Senate: Homeland Security and Governmental Affairs Committee; House: Intelligence (Permanent Select) Committee; House: Oversight and Government Reform Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
3 reports
3 reports
3 reports
WUXI BIOLOGICS USA LLC
FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
3 reports
3 reports
AGC AMERICA, INC.
K&L GATES, LLP
2 reports
2 reports
FUJIFILM HOLDINGS AMERICA CORPORATION
AKIN GUMP STRAUSS HAUER & FELD
2 reports
FUJIFILM HOLDINGS AMERICA CORPORATION
CGCN GROUP, LLC
2 reports
2 reports
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC
COVINGTON & BURLING LLP
2 reports
2 reports
All 20 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | House |
|---|---|---|---|---|---|---|
| AMGEN INC | 3 | $8.3M | Q4 2024 | Q3 2024 | yes | |
| HERITAGE ACTION FOR AMERICA | 3 | $590K | Q4 2024 | Q3 2024 | yes | |
| ILLUMINA, INC. | 3 | $950K | Q4 2024 | Q3 2024 | yes | |
| WUXI BIOLOGICS USA LLC | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) | 3 | $0 | Q4 2024 | Q3 2024 | yes |
| WUXI BIOLOGICS USA LLC | 3 | $295K | Q4 2024 | Q3 2024 | yes | |
| AGC AMERICA, INC. | K&L GATES, LLP | 2 | $230K | Q4 2024 | Q3 2024 | yes |
| FDD ACTION | 2 | $300K | Q4 2024 | Q3 2024 | yes | |
| FUJIFILM HOLDINGS AMERICA CORPORATION | AKIN GUMP STRAUSS HAUER & FELD | 2 | $0 | Q4 2024 | Q3 2024 | yes |
| FUJIFILM HOLDINGS AMERICA CORPORATION | CGCN GROUP, LLC | 2 | $0 | Q4 2024 | Q3 2024 | yes |
| FUJIFILM HOLDINGS AMERICA CORPORATION | 2 | $485K | Q4 2024 | Q3 2024 | yes | |
| GSK (FKA GLAXOSMITHKLINE INC.) | 2 | $2.4M | Q4 2024 | Q2 2024 | yes | |
| HARVARD UNIVERSITY--PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2 | $320K | Q4 2024 | Q3 2024 | yes | |
| PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC | COVINGTON & BURLING LLP | 2 | $0 | Q2 2024 | Q3 2024 | — |
| SMITH & NEPHEW, INC. | 2 | $870K | Q4 2024 | Q3 2024 | yes | |
| BEONE MEDICINES USA, INC (FORMERLY BEIGENE USA, INC.) | 1 | $160K | Q2 2024 | Q2 2024 | yes | |
| BROWN UNIVERSITY | 1 | $70K | Q4 2024 | Q4 2024 | yes | |
| IQVIA HOLDINGS, INC. | DLA PIPER LLP (US) | 1 | $60K | Q4 2024 | Q4 2024 | yes |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 1 | $7.6M | Q4 2024 | Q4 2024 | yes | |
| THE UNITED STATES PHARMACOPEIAL CONVENTION | 1 | $60K | Q3 2024 | Q3 2024 | yes | |
| VANDERBILT UNIVERSITY | 1 | $40K | Q3 2024 | Q3 2024 | yes |